Skip to content

Comparative Analysis Between Textured Insoles and Roods Technique Affecting Balance in DNP.

Comparative Analysis Between Textured Insoles and Roods Facilitatory Technique Affecting Balance in Patients With Diabetic Neuropathy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07712289
Acronym
DNP
Enrollment
44
Registered
2026-07-17
Start date
2025-03-04
Completion date
2025-05-26
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetic Neuropathy

Keywords

Diabetes, diabetic neuropathy, insoles, textured insoles, roods technique, roods facilitatory technique

Brief summary

The purpose of this randomized controlled trial is to compare the effectiveness of textured insoles versus Rood's facilitatory technique in improving balance in patients with diabetic neuropathy. The study aims to answer the following question: What is the comparative analysis between textured insoles and Rood's facilitatory techniques affecting balance in patient with diabetic neuropathy? Participants assigned into two groups. Group A received contrast bath plus Rood's facilitatory techniques, while Group B received contrast bath plus textured insoles. Treatment will be delivered over a four-week period, with three sessions per week on alternative days.

Interventions

OTHERRoods Facilitatory Technique

Quick stretch and Heavy compression technique targeted areas of lower extremities

Participants wore allocated insoles, in their own shoes, as much as possible.

Sponsors

University of Faisalabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Group A received contrast bath plus Rood's facilitatory techniques, while Group B received contrast bath plus textured insoles.

Eligibility

Sex/Gender
ALL
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Participants must have a clinical diagnosis of Type 2 diabetes. * Participants must show evidence of diabetic peripheral neuropathy (DPN) as diagnosed by clinical examination. * Participants with 25-40 Berg Balance Score. * Participants with 6-8(Patient version) and 2.5-4(Physical assessment) Michigan Neuropathy Score. * Participants aged 45 years to 60. * Participants taking medications. * Participants must be able to understand the study procedures and provide written informed consent.

Exclusion criteria

* Participants who have significant cognitive impairments (e.g., dementia) that would prevent them from understanding and adhering to study instructions. * Participants with severe PAD or significant circulatory problems that would contraindicate the use of insoles or tactile stimulation therapy. * Participants with other neurological conditions that could confound the results. * Participants who have had recent surgery or trauma to the feet or lower extremities in the past 6 months. * Participants who are involved in another clinical trial. * Participants with active diabetic foot ulcers, severe deformities, infections, or other complications that would make it unsafe or inappropriate to use textured insoles.

Design outcomes

Primary

MeasureTime frameDescription
BBSFour weeksBerg Balance Scale

Secondary

MeasureTime frameDescription
MNSIFour weeksMichigan Neuropathy Screening Instrument

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026